Potential Risk Factors for Length of Hospitalization in COVID-19 Patients: A Cross-sectional Study

Talebi-Ghane, Elaheh; Khazaei, Salman; Tapak, Leili; Soltanian, Ali Reza; Bashirian, Saeed; Keramat, Fariba; Amini, Payam; Doroh, Vajiheh Ramezani

doi:10.5812/jhealthscope.115575

Cited by 1 publication

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It seems higher hospital admission rate, prolonged length of stay, and need to the specialized treatments [2][3][4] are among the most probable reasons for increased hospitalization cost among COVID-19 patients. A study in Hamadan city, Iran showed that the median lengths of hospitalization in COVID-19 patients was five days and some demographic and clinical features were related with a higher length of stay in patients [5]. Another study revealed that being more than 60 year old, respiratory rate more than 30 per minute, having comorbidity, and having a prolonged hospitalization, the risk of mortality in COVID-19 Increased [6].…”

Section: Open Accessmentioning

confidence: 99%

Which patients bring the most costs for hospital? A study on the cost determinants among COVID-19 patients in Iran

Ramezani-Doroh

Tapak

Hamidi

et al. 2022

Cost Eff Resour Alloc

Self Cite

View full text Add to dashboard Cite

Background Accurate information on the cost determinants in the COVID-19 patients could provide policymakers a valuable planning tool for dealing with the future COVID-19 crises especially in the health systems with limited resources. Objectives This study aimed to determine the factors affecting direct medical cost of COVID-19 patients in Hamadan, the west of Iran. Methods This study considered 909 confirmed COVID-19 patients with positive real-time reverse-transcriptase polymerase-chain-reaction test which were hospitalized from 1 March to 31 January 2021 in Farshchian (Sina) hospital in Hamadan, Iran. A checklist was utilized to assess the relationship of demographic characteristics, clinical presentation, medical laboratory findings and the length of hospitalization to the direct hospitalization costs in two groups of patients (patients with hospitalization ≤ 9 days and > 9 days). Statistical analysis was performed using chi-square, median test and multivariable quantile regression model at 0.05 significance levels with Stata 14 software program. Results The median cost of hospitalization in patients was totally 134.48 dollars (Range: 19.19–2397.54) and respectively 95.87 (Range: 19.19–856.63) and 507.30 dollars (Range: 68.94–2397.54) in patients with hospitalization ≤ 9 days and > 9 days. The adjusted estimates presented that in patients with 9 or less hospitalization days history of cardiovascular disease, wheezing pulmonary lung, SPO2 lower than 90%, positive CRP, LDH higher than 942 U/L, NA lower than 136 mEq/L, lymphosite lower than 20% and patients with ICU experience had significantly positive relationship to the median of cost. Moreover, in patients with more than 9 hospitalization days, history of cardiovascular disease and ICU experience was statistically positive association and age older than 60 years and WBC lower than 4.5 mg/dL had statistically negative relationship to the median of hospitalization cost. Conclusion As the length of hospital stay, which can be associated with the severity of the disease, increases, health systems become more vulnerable in terms of resource utilization, which in turn can challenge their responsiveness and readiness to meet the specialized treatment needs of individuals.

show abstract